Betaine

Overview
Betaine, also called glycine betaine, is trimethylglycine. It occurs in beets, spinach, wheat germ and quinoa, and the body can also make it by oxidising choline. This page treats it as that food constituent and as a studied supplement, not as a substitute for choline, beetroot nitrate or a mixed diet [1,2].
In liver and kidney it is an osmolyte and the methyl donor that betaine-homocysteine methyltransferase uses to turn homocysteine into methionine [2,3]. A 2023 review of brain research finds proposed benefits in neurodegeneration and GABA-related imbalance, but the cellular mechanism and the role of the betaine-GABA transporter are not established [2]. A low-dose supplement can lower plasma homocysteine in healthy adults. That blood result is not a cognitive outcome and not a food trial [4].
Dietary Origin
Betaine occurs directly in some foods. The ten highest values in Zeisel et al. (2003) Table 1, after the erratum correction, are below. The asterisk marks that table. USDA Release 2 later reported lower values for some of the same foods, including 410 mg per 100 g in toasted wheat germ and 110–130 mg per 100 g in frozen spinach [1]. Quinoa remains a separate Release 2 record at 630 mg per 100 g and is not in this table [1]. Wheat bran, pretzels, wheat bread and graham crackers have no canonical food page, so their values stay in this table only.
| Food | Form in Table 1 | Betaine |
|---|---|---|
| Wheat bran | NDB 20077 | 1,506 mg* |
| Wheat germ | toasted, NDB 08084 | 1,395 mg* |
| Spinach | cooked | 725 mg* |
| Spinach | raw | 675 mg* |
| Beetroot | canned, NDB 11084 | 334 mg* |
| Pretzels | hard, plain, salted | 266 mg* |
| Shrimp | canned, NDB 15152 | 246 mg* |
| Wheat bread | NDB 18064 | 227 mg* |
| Graham crackers | plain | 194 mg* |
| Beetroot | raw, NDB 11080 | 129 mg* |
* Zeisel et al. (2003) Table 1, corrected by the erratum, mg per 100 g [5]. The nutrition rows on the linked food pages use the form that matches that page. Cooked spinach and canned beetroot are listed here and are not written onto the raw pages.
Choline can be oxidised to betaine in mitochondria. That is a precursor route, not evidence that a choline-rich food contains betaine [2]. Supplemental betaine is a separate exposure. Oral betaine at 6–9 g/day is a licensed treatment for homocystinuria. That dose is a medicine, not a food pattern [2].
Research Spotlights & Evidence Checks
Recipes
Foods
Biological Regulatory Systems
| Biological Regulatory System | Evidence-qualified relationship | Evidence |
|---|---|---|
| Methylation & One-Carbon Metabolism (BRS2) | Betaine is the methyl-donor substrate for betaine-homocysteine methyltransferase. A supplement can lower plasma homocysteine. That does not measure tissue enzyme flux or a cognitive outcome | [2,3,4] |
References
[1] Patterson et al. (2008). USDA Database for the Choline Content of Common Foods, Release 2. Corrected food-composition values for betaine in raw beets, quinoa, toasted wheat germ and frozen spinach, after earlier overestimates in some grain foods, seafood and spinach.
[2] Bhatt et al. (2023). Betaine—The dark knight of the brain. Identifies dietary betaine and choline oxidation, the liver and kidney methyl-donor role, and the unsettled status of brain transport and proposed neurological benefits.
[3] Evans et al. (2002). Betaine-homocysteine methyltransferase: zinc in a distorted barrel. Enzyme structure showing betaine as the methyl donor that converts homocysteine to methionine.
[4] Olthof et al. (2003). Low Dose Betaine Supplementation Leads to Immediate and Long Term Lowering of Plasma Homocysteine in Healthy Men and Women. Supplemental betaine lowered plasma homocysteine in healthy adults. Not a food trial and not a cognitive outcome.
[5] Zeisel et al. (2003). Concentrations of Choline-Containing Compounds and Betaine in Common Foods. Table 1 betaine concentrations, as corrected by the erratum because the original molecular weight was 104 rather than 117.
BRS matrix — individual KC inputs
| BRS / PM | Relationship | Biological role and limitation |
|---|---|---|
| BRS1 · BRS1-FM1-PM3 BRS2(KC1) | Supported upstream supply | Betaine donates methyl groups through BRS2 PM2 — BHMT remethylation, predominantly in liver and kidney, replenishing methionine upstream of BRS2 PM3 — SAM synthesis. SAM is used by COMT during dopamine metabolism. Limitation: This is peripheral BHMT supply, not neuronal BHMT activity or measured delivery into neural SAM. Dietary methionine and folate remethylation provide alternatives. Homocysteine lowering does not establish regional clearance, a limiting constraint or benefit from extra intake. Obeid (2013) [25] Evans et al. (2002) [27] Bailey et al. (2021) [26] Lotta et al. (1995) [29] |
| BRS1 · BRS1-FM1-PM4 BRS2(KC1) | Supported upstream supply | Betaine donates methyl groups through BRS2 PM2 — BHMT remethylation, predominantly in liver and kidney, replenishing methionine upstream of BRS2 PM3 — SAM synthesis. SAM is used by COMT during noradrenaline metabolism. Limitation: This is peripheral BHMT supply, not neuronal BHMT activity or measured delivery into neural SAM. Dietary methionine and folate remethylation provide alternatives. Homocysteine lowering does not establish regional clearance, a limiting constraint or benefit from extra intake. Obeid (2013) [20] Evans et al. (2002) [22] Bailey et al. (2021) [21] Lotta et al. (1995) [24] |
| BRS1 · BRS1-FM3-PM7 BRS2(KC1) | Supported upstream supply | Betaine donates a methyl group through hepatic BRS2 PM2 — BHMT remethylation, replenishing methionine/SAM used by BRS2 PM7 — PEMT formation upstream of DHA-bearing LPC carrier delivery. Limitation: Supported biochemical supply chain, not a demonstrated increase in net adult brain DHA incorporation. Folate/choline compensation, hepatic BHMT, SAM turnover and carrier remodelling vary by context. Mouse folate effects were sex/tissue dependent; betaine rescue used ethanol-exposed rats. The downstream human tracer study administered choline, not folate or betaine. A donor-specific limiting effect and extra-intake benefit remain unresolved. Evans et al. (2002) [17] Kharbanda et al. (2007) [14] Bailey et al. (2021) [16] Klatt et al. (2019) [11] Nguyen et al. (2014) [12] |
| BRS2 · BRS2-FM1-PM2 BRS2(KC1) | Conditional constraint | Methyl-donor substrate for BHMT remethylation of homocysteine to methionine Limitation: Supplemental betaine lowers plasma homocysteine in healthy adults, but that change does not measure tissue BHMT activity or show a clinical benefit. Human evidence is an eight-man depletion pilot, with the challenge response in four clinically depleted participants; tissue BHMT flux was not measured. Rat donor rescue and specific inhibition support the chain. This does not establish ordinary-diet limitation, response in every tissue or benefit above adequacy. Folate’s indirect constraint on BHMT remains unresolved. Evans et al. (2002) [1] Breksa and Garrow (1999) [2] Olthof et al. (2003) [5] |
| BRS2 · BRS2-FM1-PM3 BRS2(KC1) | Supported upstream supply | Betaine donates a methyl group through PM2 — Betaine/BHMT remethylation to regenerate methionine used by PM3. Limitation: BHMT activity is concentrated mainly in liver and kidney; this is not local BHMT activity in every tissue. Folate-dependent remethylation and dietary methionine provide alternative supply. Homocysteine lowering does not establish increased MAT flux, increased SAMe availability or benefit from extra intake in replete individuals. Obeid (2013) [8] Evans et al. (2002) [9] |
| BRS2 · BRS2-FM1-PM4 BRS2(KC1) | Supported upstream supply | Betaine donates a methyl group through PM2 — Betaine/BHMT remethylation to regenerate methionine returned to the integrated methionine cycle. Limitation: BHMT activity is concentrated mainly in liver and kidney; this is not local BHMT activity in every tissue. Folate-dependent remethylation and dietary methionine provide alternative supply. Homocysteine lowering does not establish increased MAT flux, increased SAMe availability or benefit from extra intake in replete individuals. Obeid (2013) [17] Evans et al. (2002) [18] |
| BRS2 · BRS2-FM3-PM7 BRS2(KC1) | Conditional constraint | Betaine can support the methyl-donor supply used by hepatic PEMT; supplementation restored SAM:SAH balance and reported PEMT-mediated PC production in ethanol-fed rats. Limitation: Abstract-level rescue evidence under ethanol-induced imbalance does not establish ordinary betaine deficiency, universal intake responsiveness or cognitive benefit; full assay methods remain unavailable. Kharbanda et al. (2007) [12] |







